Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.

Respir Res · 2021 · PMC8240400 · PMID 34183009

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

borderline significancep = 0.05actually significant

Their results showed that the biomarker achieved a significant performance for NSCLC lesions (AUC = 0.83, p < 0.001) and borderline significance for melanoma lymph nodes (AUC = 0.64, p = 0.05).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.